125 related articles for article (PubMed ID: 9717967)
1. Immunological study on CD3 defective cutaneous T cell lymphoma cells from a patient with Sézary syndrome.
Sano S; Matsui Y; Itami S; Yoshikawa K
Clin Exp Immunol; 1998 Aug; 113(2):190-7. PubMed ID: 9717967
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of cutaneous T-cell lymphoma cells with superantigenic staphylococcal toxins.
Tokura Y; Heald PW; Yan SL; Edelson RL
J Invest Dermatol; 1992 Jan; 98(1):33-7. PubMed ID: 1728639
[TBL] [Abstract][Full Text] [Related]
3. Defective TCR surface expression associated with impaired TCR beta-chain assembly in a patient with cutaneous T-cell lymphoma.
Fischer MB; Hauber I; Födinger M; Wolf HM; Thon V; Donath P; Eibl MM; Knobler RM
J Invest Dermatol; 1995 Apr; 104(4):537-40. PubMed ID: 7706773
[TBL] [Abstract][Full Text] [Related]
4. Single TCR-Vβ2 evaluation discloses the circulating T cell clone in Sezary syndrome: one family fits all!
Scala E; Abeni D; Pomponi D; Russo N; Russo G; Narducci MG
Arch Dermatol Res; 2015 Aug; 307(6):487-93. PubMed ID: 25733488
[TBL] [Abstract][Full Text] [Related]
5. Nonerythrodermic, leukemic variant of cutaneous T-cell lymphoma with indolent clinical course: Th2-type tumor cells lacking T-cell receptor/CD3 expression and coinfiltrating tumoricidal CD8 T cells.
Tokura Y; Yagi H; Seo N; Takagi T; Takigawa M
J Am Acad Dermatol; 2000 Nov; 43(5 Pt 2):946-54. PubMed ID: 11044831
[TBL] [Abstract][Full Text] [Related]
6. Engagement of ILT2/CD85j in Sézary syndrome cells inhibits their CD3/TCR signaling.
Nikolova M; Musette P; Bagot M; Boumsell L; Bensussan A
Blood; 2002 Aug; 100(3):1019-25. PubMed ID: 12130517
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
Edelson RL
Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous colonization with staphylococci influences the disease activity of Sézary syndrome: a potential role for bacterial superantigens.
Tokura Y; Yagi H; Ohshima A; Kurokawa S; Wakita H; Yokote R; Shirahama S; Furukawa F; Takigawa M
Br J Dermatol; 1995 Jul; 133(1):6-12. PubMed ID: 7669641
[TBL] [Abstract][Full Text] [Related]
9. T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings.
Ponti R; Quaglino P; Novelli M; Fierro MT; Comessatti A; Peroni A; Bonello L; Bernengo MG
Br J Dermatol; 2005 Sep; 153(3):565-73. PubMed ID: 16120144
[TBL] [Abstract][Full Text] [Related]
10. Bacterial proteins that mediate the association of a defined subset of T cell receptor:CD4 complexes with class II MHC.
Yagi J; Baron J; Buxser S; Janeway CA
J Immunol; 1990 Feb; 144(3):892-901. PubMed ID: 2136903
[TBL] [Abstract][Full Text] [Related]
11. Isolation of a CD8alphaalpha+ CD4- tumour T-cell clone with cytotoxic activity from a CD4+ CD8- cutaneous T-cell lymphoma.
Nikolova M; Echchakir H; Wechsler J; Boumsell L; Bensussan A; Bagot M
Br J Dermatol; 2003 Jan; 148(1):24-9. PubMed ID: 12534590
[TBL] [Abstract][Full Text] [Related]
12. Evidence for restricted Vbeta usage in the leukemic phase of cutaneous T cell lymphoma.
Vonderheid EC; Boselli CM; Conroy M; Casaus L; Espinoza LC; Venkataramani P; Bigler RD; Hou JS
J Invest Dermatol; 2005 Mar; 124(3):651-61. PubMed ID: 15737208
[TBL] [Abstract][Full Text] [Related]
13. Circulating clonal CLA(+) and CD4(+) T cells in Sezary syndrome express the skin-homing chemokine receptors CCR4 and CCR10 as well as the lymph node-homing chemokine receptor CCR7.
Sokolowska-Wojdylo M; Wenzel J; Gaffal E; Lenz J; Speuser P; Erdmann S; Abuzahra F; Bowman E; Roszkiewicz J; Bieber T; Tüting T
Br J Dermatol; 2005 Feb; 152(2):258-64. PubMed ID: 15727636
[TBL] [Abstract][Full Text] [Related]
14. FOXP3+CD25- tumor cells with regulatory function in Sézary syndrome.
Heid JB; Schmidt A; Oberle N; Goerdt S; Krammer PH; Suri-Payer E; Klemke CD
J Invest Dermatol; 2009 Dec; 129(12):2875-85. PubMed ID: 19626037
[TBL] [Abstract][Full Text] [Related]
15. Analysis of T cell stimulation by superantigen plus major histocompatibility complex class II molecules or by CD3 monoclonal antibody: costimulation by purified adhesion ligands VCAM-1, ICAM-1, but not ELAM-1.
van Seventer GA; Newman W; Shimizu Y; Nutman TB; Tanaka Y; Horgan KJ; Gopal TV; Ennis E; O'Sullivan D; Grey H
J Exp Med; 1991 Oct; 174(4):901-13. PubMed ID: 1717633
[TBL] [Abstract][Full Text] [Related]
16. Staphylococcus aureus enterotoxins induce FOXP3 in neoplastic T cells in Sézary syndrome.
Willerslev-Olsen A; Buus TB; Nastasi C; Blümel E; Gluud M; Bonefeld CM; Geisler C; Lindahl LM; Vermeer M; Wasik MA; Iversen L; Becker JC; Andersen MH; Gjerdrum LMR; Litvinov IV; Litman T; Krejsgaard T; Woetmann A; Ødum N
Blood Cancer J; 2020 May; 10(5):57. PubMed ID: 32409671
[TBL] [Abstract][Full Text] [Related]
17. Lack of T-cell receptor-induced signaling is crucial for CD95 ligand up-regulation and protects cutaneous T-cell lymphoma cells from activation-induced cell death.
Klemke CD; Brenner D; Weiss EM; Schmidt M; Leverkus M; Gülow K; Krammer PH
Cancer Res; 2009 May; 69(10):4175-83. PubMed ID: 19435902
[TBL] [Abstract][Full Text] [Related]
18. Accessory cell function of a human colonic epithelial cell line HT-29 for bacterial superantigens.
Liu ZX; Sugawara S; Hiwatashi N; Noguchi M; Rikiishi H; Kumagai K; Toyota T
Clin Exp Immunol; 1997 Jun; 108(3):384-91. PubMed ID: 9182880
[TBL] [Abstract][Full Text] [Related]
19. A distinct profile of serum levels of soluble intercellular adhesion molecule-1 and intercellular adhesion molecule-3 in mycosis fungoides and Sézary syndrome.
López-Lerma I; Estrach MT
J Am Acad Dermatol; 2009 Aug; 61(2):263-70. PubMed ID: 19615537
[TBL] [Abstract][Full Text] [Related]
20. Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sézary syndrome from other cutaneous T-cell lymphomas.
Klemke CD; Fritzsching B; Franz B; Kleinmann EV; Oberle N; Poenitz N; Sykora J; Banham AH; Roncador G; Kuhn A; Goerdt S; Krammer PH; Suri-Payer E
Leukemia; 2006 Jun; 20(6):1123-9. PubMed ID: 16557241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
